Clinical trial Recruiting at 1 site Observational Ages 18 to 65

See if pelvic floor endurance relates to stent symptoms after ureteroscopy

Official title: Development and Clinical Evaluation of the Pelvic Floor Fatigue Index (PFFI): A Prospective Observational Study

Run by Trabzon Kanuni Education and Research Hospital · NCT07763613 · Data updated 2026-11-12

This study tests whether a ultrasound measure of pelvic floor endurance (PFFI) can predict ureteral stent-related symptoms after ureteroscopy or RIRS in adults 18–65.

More Urolithiasis trials

Quick facts

Study typeObservational
Ages18 Years to 65 Years
SexAll
Enrollment75 (estimated)
SponsorTrabzon Kanuni Education and Research Hospital
Academic / other
Locations1 site (Trabzon, Trabzon)
StatusRecruiting
StartedAugust 13, 2026
Main results expectedDecember 25, 2026
Study endsDecember 25, 2026
Registry record updatedAugust 18, 2026
Trial IDNCT07763613 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–65 years with urolithiasis scheduled for URS or RIRS and planned double-J stent placement, who can read Turkish and complete USSQ.

Probably not a fit

Patients who do not have measurable pelvic floor endurance differences or who do not experience stent-related symptoms may not benefit from PFFI information.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective observational study evaluates whether the Pelvic Floor Fatigue Index (PFFI), an ultrasound-based measure of pelvic floor endurance, is associated with postoperative ureteral stent symptoms as reported on the Ureteral Stent Symptom Questionnaire (USSQ). Participants undergoing URS or RIRS with planned double-J stent placement will have preoperative PFFI measurements and later USSQ assessments. The study also examines test-retest reliability of the PFFI and its relation to stent-related symptom severity. The aim is to identify whether pelvic floor endurance contributes to interindividual variability in stent-related experiences beyond surgical factors. By understanding these associations, clinicians may better anticipate symptom burden and tailor perioperative care.

Why it matters

Potential benefit: If successful, PFFI could help predict which patients are more likely to experience stent-related symptoms and guide personalized management.

How similar studies have gone: Previous work shows symptom variability is multifactorial; this is a novel application of ultrasound-based pelvic floor endurance assessment in this setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Adults aged 18-65 years. Diagnosis of urolithiasis requiring ureteroscopy (URS) or retrograde intrarenal surgery (RIRS).

Planned postoperative double-J ureteral stent placement. Patients belonging to either the Non-pre-stented Group or the Pre-stented Group according to the study protocol.

Ability to read and understand the validated Turkish version of the Ureteral Stent Symptom Questionnaire (USSQ).

Ability to independently complete the USSQ. Ability to perform an adequate voluntary pelvic floor muscle contraction. Provision of written informed consent.

Exclusion Criteria:

Clinically significant diabetic neuropathy. Neurological disorders affecting lower urinary tract function (e.g., multiple sclerosis, Parkinson's disease, spinal cord injury).

Active lower urinary tract dysfunction (e.g., overactive bladder, neurogenic bladder, interstitial cystitis).

Previous pelvic floor surgery. Known urinary incontinence. Urethral stricture. Chronic prostatitis. Recurrent urinary tract infection. Urinary tract malignancy. Advanced chronic kidney disease. Previous upper urinary tract reconstructive surgery. Pregnancy. Active urinary tract infection. Inability to perform an adequate voluntary pelvic floor muscle contraction. Inability to provide informed consent.

Where it's running

  • Trabzon Kanuni Education and Research Hospital
    Trabzon, Trabzon, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.